Last week’s full-year results from GlaxoSmithKline (GSK) do not answer every concern the sceptics may have regarding current ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Record FY2024 development sales of AED 33.6 billion, up 20% YoY driven by strong demand for new launches and existing ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

This is the conclusion of a recent analysis by commercial real estate investment firm Berkadia, which predicts Orlando will ...

Refine unveils its state-of-the-art new HQ and Sales Gallery in the sky on 47th floor of Ubora Tower in Business Bay spanning ...

Meanwhile, vaccine sales slipped by 4% for the year ... and GSK has to prove its drug development pipeline is packed with new blockbuster treatments. “An increased dividend and the launch ...

It said it expects further growth to be boosted by its strong pipeline of ... now in clinical development. As a result, the company said it is targeting total sales of more than £40 billion ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...